Literature DB >> 11524815

[Simple method of stereotactic radiotherapy without stereotactic body frame for extracranial tumors].

Y Takai1, M Mituya, K Nemoto, Y Ogawa, Y Kakuto, H Matusita, K Takeda, C Takahashi, S Yamada.   

Abstract

Thirty-five patients with metastatic lung cancer(46 lesions) and twenty patients with primary lung cancer (21 lesions) have been treated with a simple method of stereotactic radiotherapy (SRT) without stereotactic body frame. Tumor size ranged from 1-4 cm in diameter. We used Vac-Lok cushion(Med-Tek) as a immobilization system. To be sure to include the respiratory movement of tumor to planning target volume(PTV), every patients were examined by fluoroscopy and radio-opaque catheters with the same length of tumor movement were attached on the anterior and lateral chest wall before CT simulation. A gold grain was implanted into a tumor that was invisible on fluoroscopy, as a radiomaker. Protocol of 60 Gy/8 fractions/2 weeks and 45 Gy/3 fractions/3-6 days were mainly used. The median follow-up period was 15 months for primary lung cancer and 19 months for metastatic lung cancer. Local control rates were 91% for metastatic lung cancer, 89% for primary lung cancer and 85% for T1, 2N0M0 cases. All patients developed mild pneumonitis or fibrosis about 4.5 months after SRT just in the treatment volume. Only three patients was symptomatic.

Entities:  

Mesh:

Year:  2001        PMID: 11524815

Source DB:  PubMed          Journal:  Nihon Igaku Hoshasen Gakkai Zasshi        ISSN: 0048-0428


  2 in total

1.  Risk factors for radiation pneumonitis after stereotactic radiation therapy for lung tumours: clinical usefulness of the planning target volume to total lung volume ratio.

Authors:  Tomoko Ueyama; Takeshi Arimura; Koji Takumi; Fumihiko Nakamura; Ryutaro Higashi; Soichiro Ito; Yoshihiko Fukukura; Tomokazu Umanodan; Masanori Nakajo; Chihaya Koriyama; Takashi Yoshiura
Journal:  Br J Radiol       Date:  2018-04-16       Impact factor: 3.039

2.  Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors.

Authors:  Hideomi Yamashita; Keiichi Nakagawa; Naoki Nakamura; Hiroki Koyanagi; Masao Tago; Hiroshi Igaki; Kenshiro Shiraishi; Nakashi Sasano; Kuni Ohtomo
Journal:  Radiat Oncol       Date:  2007-06-07       Impact factor: 3.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.